Galapagos | GLPG - Market Capitalization

Stock Price
25.60
Daily Change
-0.34 -1.31%
Monthly
-9.86%
Yearly
15.94%
Q2 Forecast
24.95

Galapagos reported EUR1.69B in Market Capitalization this April of 2026, considering the latest stock price and the number of outstanding shares.





Market Capitalization Change Date
argenx SE USD 51.83B 7.52B Dec/2025
AstraZeneca USD 288.15B 55.08B Dec/2025
Biogen USD 25.82B 5.28B Dec/2025
Genmab DKK 20.48B 1.02B Dec/2025
Gilead Sciences USD 152.28B 14.55B Dec/2025
GlaxoSmithKline GBP 74.36B 10.31B Dec/2025
Hikma Pharmaceutical USD 4.63B 1.42B Dec/2025
Incyte USD 19.39B 2.83B Dec/2025
Merck EUR 53.3B 5.72B Dec/2025
Neurocrine Biosciences USD 14.14B 218M Dec/2025
Novartis USD 292.21B 26.55B Dec/2025
Roche Holding CHF 266.34B 55.46B Dec/2025
Sanofi EUR 100.88B 4.46B Dec/2025
UCB EUR 46.41B 13.94B Dec/2025
Vertex Pharmaceuticals USD 115.03B 14.61B Dec/2025